A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but \<20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level intervention consisting of: 1) patient survivorship education via telehealth with the cancer center, 2) ongoing patient-tailored education program within the electronic health record patient portal, 3) a structured interactive phone communication between the cancer center and the primary care clinic, and 4) an in-person visit with the primary care clinic for survivorship care with the goal of achieving high rates of adherence to recommended surveillance for late effects, as well as improving patient and physician knowledge and self-efficacy. If this scalable intervention demonstrates patient completion of recommended care comparable to cancer center survivorship clinics, this innovative study has the enormous potential to deliver recommended care to a larger proportion of childhood cancer survivors and reduce survivorship care disparities, while engaging p to integrate survivorship care as part of overall, lifelong health maintenance.
Conditions:
🦠 Childhood Cancer 🦠 Survivorship 🦠 Health Care Utilization 🦠 Health Knowledge, Attitudes, Practice 🦠 Adherence, Patient
🗓️ Study Start (Actual) 1 January 2023
🗓️ Primary Completion (Estimated) 28 February 2026
✅ Study Completion (Estimated) 31 August 2026
👥 Enrollment (Estimated) 240
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Long Beach, California, United States
📍 Denver, Colorado, United States
📍 Hackensack, New Jersey, United States
📍 Chapel Hill, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Diagnosed with any cancer at age \<21 years
    • 2. Treated with chemotherapy and/or radiation
    • 3. 2.0-4.0 years status post-completion of all cancer-related therapy
    • 4. Cancer-free with a life expectancy of ≥2 years
    • 5. English- or Spanish-speaking (also applies to parent/guardian if patient age \<18 years)
    • 6. No previous attendance at a specialty survivorship clinic
    • 7. Followed at one of the 4 participating sites: Hackensack, University of North Carolina- Chapel Hill (UNC), University of Colorado Denver (CU), Miller's Children's and Women's Hospital Long Beach (MCWH)

    Exclusion Criteria:

    • * Active medical problems severe enough to not be eligible for receiving survivorship care with primary care provider at the time of recruitment
Ages Eligible for Study: 2 Years to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 16 June 2022
  • First Submitted that Met QC Criteria 4 July 2022
  • First Posted 7 July 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 17 July 2024
  • Last Update Posted 18 July 2024
  • Last Verified July 2024